Description
Nitrendipine is an L-type calcium channel blocker which research has shown to have a potent inhibitory effect on human carboxylesterase, a member of the serine hydrolase family, in vitro.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Nitrendipine is an L-type calcium channel blocker which research has shown to have a potent inhibitory effect on human carboxylesterase, a member of the serine hydrolase family, in vitro.
| Cas No. | 39562-70-4 |
|---|---|
| Purity | ≥98% |
| Formula | C18H20N2O6 |
| Formula Wt. | 360.37 |
| Chemical Name | 5-O-ethyl 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| IUPAC Name | Ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate |
| Synonym | Baypress, Bayotensin, Nidrel |
| Solubility | soluble 2mg/ml in ethanol, 25mg/ml in DMSO, and 30mg/ml in DMF, sparingly soluble in aqueous buffers |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Ohno S, Yokoi H, Mori K, et al. Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure. Sci Rep. 2016 Jun 7; 6:27192. PMID: 27273361.
Yanjiao X, Chengliang Z, Xiping L, et al. Evaluation of the inhibitory effects of antihypertensive drugs on human carboxylesterase in vitro. Dru Metab Pharmacokinet. 2013; 28(6):468-474. PMID: 23648675.
CDK2 inhibitor
EGFR, VEGFR inhibitor.
Trichothecene mycotoxin produced by Fusarium, a...
5-HT3 antagonist.
Thiol derivative, antioxidant.
Endogenous peptide hormone fragment, involved i...
NMDA NR1/NR2B antagonist.
Semi-synthetic avermectin; GABA potentiator.
Polymethoxylated flavone found in citrus fruits...
BHA derivative; potential Ca2+ ATPase inhibitor...
RIP1 inhibitor.
β-lactam cephalosporin; penicillin binding pro...
Alkaloid found in Sophora.
Non-steroidal MRA
Sulforaphane homolog, ITC found in cruciferous ...
Diterpene found in roasted coffee.
NSAID; PG synthetase inhibitor.
Fermentation impurity
Synthesis intermediate
BRD2/3/4 inhibitor.